Metastatic Adenocarcinoma of the Esophagus Completed Phase 2 Trials for Oxaliplatin (DB00526)

IndicationStatusPhase
DBCOND0039078 (Metastatic Adenocarcinoma of the Esophagus)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00591123Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric CardiaTreatment